I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Supplementary Data 1 from Absence of BTK , BCL2 , and PLCG2..:
Nitin Jain
;
Lisa J. Croner
;
John N. Allan
...
doi:10.1158/1078-0432.25124601.v1. , 2024
Link:
https://doi.org/10.1158/1078-0432.25124601.v1
RT Journal T1
Supplementary Data 1 from Absence of BTK , BCL2 , and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax
UL https://suche.suub.uni-bremen.de/peid=base-ftgriffithunifig:oai:figshare.com:article_25124601&Exemplar=1&LAN=DE A1 Nitin Jain A1 Lisa J. Croner A1 John N. Allan A1 Tanya Siddiqi A1 Alessandra Tedeschi A1 Xavier C. Badoux A1 Karl Eckert A1 Leo W.K. Cheung A1 Anwesha Mukherjee A1 James P. Dean A1 Edith Szafer-Glusman A1 John F. Seymour YR 2024 K1 Cancer K1 Therapeutic Research and Development K1 Clinical Research and Trials K1 Epidemiology K1 Clinical Trial Results K1 Phase II clinical trials K1 Genetics of Cancer Risk & Outcome K1 Hematological Cancers K1 Leukemias K1 Small Molecule Agents K1 Kinase inhibitors JF doi:10.1158/1078-0432.25124601.v1 LK http://dx.doi.org/https://doi.org/10.1158/1078-0432.25124601.v1 DO https://doi.org/10.1158/1078-0432.25124601.v1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)